Aclaris Therapeutics ACRS
- modzatinib — Atopic Dermatitis Phase 2
- lepzacitinib — Atopic Dermatitis Phase 2
- modzatinib — Lichen Planus Phase 1
JAK3 (1 companies · 3 programs)
Companies with an active program directed at JAK3.
Companies with an active program directed at JAK3.